Categorical versus continuous circulating tumor cell enumeration as early surrogate marker for therapy response and prognosis during docetaxel therapy in metastatic prostate cancer patients
Crossref DOI link: https://0-doi-org.brum.beds.ac.uk/10.1186/s12885-015-1478-4
Published Online: 2015-06-09
Published Print: 2015-12
Update policy: https://0-doi-org.brum.beds.ac.uk/10.1007/springer_crossmark_policy
Thalgott, Mark
Rack, Brigitte
Eiber, Matthias
Souvatzoglou, Michael
Heck, Matthias M.
Kronester, Caroline
Andergassen, Ulrich
Kehl, Victoria
Krause, Bernd J.
Gschwend, Jurgen E.
Retz, Margitta
Nawroth, Roman
License valid from 2015-06-09